Literature DB >> 454498

Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis.

E R Hurd, A Chubick, H E Jasin, M Ziff.   

Abstract

Sera from patients with Felty's syndrome (FS) and rheumatoid arthritis (RA) were examined for the presence of circulating immune complexes (IC) by using the 125I-C1q binding and monoclonal rheumatoid factor (mRF) techniques. Of 15 patients with FS, 9 (60%) had high 125I-C1q binding as compared to 3 of 26 RA patients (12%). The average C1q binding was significantly higher in the FS patients than in the RA patients without FS. C1q binding in both FS and RA patients was significantly higher than a group of 90 normal controls. In addition, serum C4 levels were significantly lower in the FS patients than in the RA patients. In contrast to these findings, IC levels in FS and RA patients were very similar when measured by the mRF technique. These studies indicate that FS patients have higher levels of complement-fixing IC in their sera than RA patients without FS. These findings raise the possibility that the complement-fixing IC found in these patients may play a role in the pathogenesis of neutropenia of FS.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454498     DOI: 10.1002/art.1780220702

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes.

Authors:  K Merétey; A Falus; U Böhm; H Permin; A Wiik
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Effect of circulating immune complexes on the binding of rheumatoid factor to histones.

Authors:  H A Gussin; K L Russo; M Teodorescu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  GM-CSF and G-CSF in Felty's syndrome.

Authors:  D R Wagner; C Combe; U Gresser
Journal:  Clin Investig       Date:  1993-02

6.  Neutropenia in rheumatoid arthritis: studies on possible contributing factors.

Authors:  R C Bucknall; P Davis; P A Bacon; J V Jones
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

7.  Immune complexes and the pathogenesis of neutropenia in Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E de Vries; J H van Krieken; A Cats
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

8.  Activation of human complement by immunoglobulin G antigranulocyte antibody.

Authors:  P K Rustagi; M S Currie; G L Logue
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

9.  Felty syndrome: autoimmune neutropenia or immune-complex-mediated disease?

Authors:  F C Breedveld; G J Lafeber; G Doekes; F H Claas; A Cats
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

10.  Human neutrophil swelling induced by immune complexes and aggregated IgG.

Authors:  E R Hurd; Y Hashimoto
Journal:  Inflammation       Date:  1981-09       Impact factor: 4.092

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.